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Abstract
Introduction: Henoch-Schönlein purpura is a systemic disease with frequent renal involvement, characterized by
IgA mesangial deposits. Streptococcal infection can induce an abnormal IgA immune response like Henoch-
Schönlein purpura, quite similar to typical acute post-infectious glomerulonephritis. Indeed, hypocomplementemia
that is typical of acute glomerulonephritis has also been described in Henoch-Schönlein purpura.
Case presentation: We describe a 14-year-old Caucasian Spanish girl who developed urinary abnormalities and
cutaneous purpura after streptococcal infection. Renal biopsy showed typical findings from Henoch-Schönlein
purpura nephritis. In addition, she had low serum levels of complement (C4 fraction) that persisted during follow-
up, in spite of her clinical evolution. She responded to treatment with enalapril and steroids.
Conclusion: The case described has, at least, three points of interest in Henoch-Schönlein purpura: 1) Initial
presentation was preceded by streptococcal infection; 2) There was a persistence of low serum levels of
complement; and 3) There was response to steroids and angiotensin-converting enzyme inhibitor in the presence
of nephrotic syndrome. There are not many cases described in the literature with these characteristics. We
conclude that Henoch-Schönlein purpura could appear after streptococcal infection in patients with abnormal
complement levels, and that steroids and angiotensin-converting enzyme inhibitor could be successful treatment
for the disease.
Introduction
Henoch-Schönlein purpura (HSP) is a systemic disease
with frequent renal involvement, characterized by IgA
mesangial deposits. Its etiology is unknown, but several
infections have been described as trigger agents [1].
Streptococcal infection could induce an abnormal IgA
immune responses like HSP, quite similar to typical
acute post-infectious glomerulonephritis (AGN) [2,3].
Indeed, hypocomplemetemia that is typical of AGN has
been also described in HSP [4].
We describe a young girl patient who developed urin-
ary abnormalities and cutaneous purpura after strepto-
coccal infection. Renal biopsy showed findings typical of
HSP nephritis, with prominent mesangial IgA deposits.
In addition, she had low serum levels of C4 that persist
during follow-up, in spite of her clinical evolution. We
conclude that HSP can appear after streptococcal infec-
tion in patients with abnormal complement levels.
Case presentation
A 14-year-old Caucasian Spanish girl without previous
diseases or known renal diseases, had an upper respira-
tory tract infection in December 2007 with malaise, no
cough, tonsilar swelling, sore throat and fever >38°C,
which were treated with codeine and acetaminophen.
Four weeks later, she developed arthralgias and asthenia
followed by purpura on legs, arms and abdomen. There
was no abdominal pain or oedema. During physical
examination, blood pressure was 100/45 mmHg and she
did not have oedemas; she presented palpable purpura.
Urine analysis revealed microscopic haematuria, protei-
nuria (ratio protein/creatinine 3.4 mg/mg) and granular
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casts with normal renal function (serum creatinine 0.8
mg/dl). Some other laboratory findings were: haemoglo-
bin 12.7 g/dl, white cell count 6300 μ, platelet count
226000 μl, antistreptolisin-O 465 U/ml (normal under
240), serum total proteins 6 g/dL and albumin 3.7 g/dL.
Coagulation study was not altered. ANA, anti-DNA,
ANCAS, antibodies anti-MBG, crioglobulins, lupus
anticogalulant and anticardiolipin antibodies were nega-
tives. IgG 969 mg/dl, IgA 150 mg/dl, IgM 93 mg/dl. C3
87 mg/dl and C4 low (13 mg/dl, normal interval 15-45).
Abdominal ultrasound revealed normal kidneys. We
performed biopsies of the purpuric lesions and the kid-
ney. In the former, there was leukocytoclastic vasculitis.
Upon renal biopsy, we examined 42 glomeruli with dif-
fuse proliferative endocapillary proliferation with a cer-
tain degree of mesangial proliferation and increased
mesangial matrix, without humps, leukocyte infiltration
or crescents. Moreover, there was no vasculitis. Direct
immunofluorescence revealed the deposition of granular
IgA and with less intensity C3 and fibrinogen in the
mesangium. The lesions were graded according to ISKD
and were classified as stages II (Figure 1).
Ultrastructural study with electronic microscopy was
not done. Treatment was initiated with oral prednisone
1 mg/Kg/day. Nevertheless, the illness of our patient
evolved to overt nephrotic syndrome (hypoalbuminemia,
oedemas) and enalapril (5 mg/day) plus aspirin (100
mg/day) were added as treatment. Prednisone was main-
tained for 16 weeks with progressive dose tapering. Sub-
sequently, we observed the progressive decrease of
proteinuria that remitted completely (Figure 2). In the
last revision, performed nine months after initial presen-
tation, our patient only had microhaematuria as unique
manifestation of renal disease. Serum ASLO indeed
decreased by more than 50% compared to initial values.
Curiously, our patient maintained low levels of serum
C4 without modification of serum C3 levels. See the
evolution at Figure 3.
Discussion
The case described has, at least, three points of interest
in HSP: 1) Initial presentation was preceded by strepto-
coccal infection; 2) There was persistence of low serum
levels of C4; and 3) There was response to steroids and
angiotensin converting enzyme inhibitor (ACEI) in the
presence of nephrotic syndrome. We are going to dis-
cuss these points in the following paragraphs.
Both AGN and HSP nephritis could appear after anti-
gen exposure with similar clinical presentation such
hematuria, edemas and hypertension [2,5,6]. In this case,
streptococcus infection was supported by clinical data
and high serum ASLO levels that decreased subse-
quently. Moreover, the clinical picture and the absence
of diabetes or other debilitating diseases indicates that
the presence of staphyloccocus infection-associated glo-
merulonephritis mimicking IgA nephropathy seems
unlikely [7]. On the one hand, the presence of hypo-
complementemia would make AGN to be a more likely
diagnosis. Although in this GN the complement system
is usually activated by alternative pathway, it has been
described as the activation by classical pathway, charac-
terized by low levels of C4 without decrease of C3, as
we observed in our patient. Moreover, GNA has also
been described as having the presence of systemic vas-
culitis affecting skin, bowel and other organs mimicking
HSP [5,6]. On the other hand, the presence of purpura
and absence of typical nephritic syndrome supported
the diagnosis of HSP. Indeed, it has been also described
that ASLO titer positivity is associated with a significant
increase in the risk of HSP and renal involvement is
more common among cases with positive elevated titers
[8].
Finally, renal biopsy was essential to establish defini-
tive diagnosis, as occured in many glomerular diseases.
The presence of mesangial proliferation without leuko-
cyte infiltration and the presence of IgA deposits led us
to a definitive diagnosis of HSP. These findings remark
the importance of renal biopsy in the diagnosis of the
majority of glomerular diseases because clinical manifes-
tations may be similar in many different glomerular dis-
eases [9]. We think that our patient did not have
superimposed minimal change disease, although it is
impossible to ensure since we did not do an electronic
microscopy study. However, if the biopsy of our patient
had podocyte fusion, it would explain by nephrotic pro-
teinuria as an unspecific finding.
Although there are no serum markers of HSP, the
increase of serum IgA in more than 50% of patients
without modification of complement serum levels has
been found [10]. However, in some patients with HSP
nephritis transient hypocomplemetemia may appear [4].
Indeed, congenital defects of complement fractions are
recognized predisposing factors in the development of
other systemic diseases such as lupus erythematosus,
Sjögren and connective tissue diseases. Furthermore,
several authors have described in HSP the presence of
low C4 serum levels in acute phase of nephritis in 17%,
and about 20% in chronic evolution. This hypocomple-
metemia is not related to the severity of the disease in
most of patients [4].
In our case, the low C4 levels did not have any rela-
tion with the severity of renal evolution. Whether the
hypocomplementemia is the result of complement acti-
vation after immunological activation from immune
complex or indicates a congenital defect is difficult to
clarify. In our case, the presence of low serum levels of
C4, irrespective of clinical evolution, allows us to con-
sider a congenital deficit because when nephropathy
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Figure 1 Photomicrographs of kidney biopsy specimens. (A and B) Endocapillary diffuse proliferation with irregular distribution among
glomerular segments. (C) Mesangial deposits of IgA with some parietal deposits and (D) deposits of C3 in mesangial areas.
Figure 2 Analytical evolution.
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reached complete remission, the levels of serum C4
remained low.
Recently, it has been described that C4 null alleles
were significantly more common among HSP patients
than in controls and so children with C4 deficiencies
may have increased risk of developing HSP [11].
Furthermore, the C4 congenital deficit is the most fre-
quent complement congenital deficit, which in many
occasions has no clinical consequences. However, in
patients with other immunological alterations such
abnormal IgA1 O-glycosilation [12], the infection with
streptococcal antigens -or other antigenic stimuli- could
trigger the development of HSP nephritis, as we
observed in our case.
On the other hand, the so called “Nephritis-Asso-
ciated-Plasmin-Receptor” (NAPlr) which has been found
in the glomeruli and in sera of many patients with AGN
[13,14] has been also found in renal glomeruli in 10/33
of patients with PSH and it is likely that the deposition
of NAPlr in the mesangium may have a role in the
pathogenesis of HSP [15]; and this antigen may be
related to the pathogenesis in some patients with SHP
[16]. It is attractive to speculate about streptococcal
infection being involved in both GN, with the
participation of NAPlr antigen. In our case, we can
speculate that streptococcal infection in a patient with
abnormal IgA response and congenital complement
abnormalities derives from the development of HSP
nephritis.
The treatment of HSP is controversial and the use of
steroids and immunosuppressive drugs must be reserved
for cases with a severe form of presentation. Corticos-
teroids produce consistent benefits and reduce the odds
of developing persistent renal disease [17]. In our case,
the development of nephrotic syndrome allows us to
start treatment with steroids and the evolution was
quite good. In our patient, we added a low dose of ena-
lapril as an antiproteinuric measure, despite our patient
having a completely normal blood pressure because of
the well demonstrated beneficial effect of ACEI in idio-
pathic IgA nephropathy [18]. Therefore, the use of
ACEI would certainly influence its evolution.
Conclusion
We conclude that HSP could appear after streptococcal
infection in patients with abnormal complement levels
and irreversible glomerular injury could be prevented if
treatment with steroids were initiated early.
Figure 3 Evolution of serum levels of complement.
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Consent
Written informed consent was obtained from the par-
ents of our patient for publication of this case report
and accompanying images. A copy of the written con-
sent is available for review by the Editor-in-Chief of this
journal.
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